NIH Funding, Research Productivity, and Scientific Impact: a 20-Year Study

NIH Funding, Research Productivity, and Scientific Impact: a 20-Year Study

The paper addresses the problems of admissibility of human embryo analysis and the authorized safety to be acknowledged, in gentle of the rising significance that scientific analysis has been gaining within the medical and biomedical fields of embryonic stem cells for therapeutic functions. As for human embryo experimentation, notably on cryopreserved supernumerary embryos, European laws varies, for the reason that European Court docket has granted member States a large margin of appreciation.

Some nations, together with Italy, have strict laws defending embryos from the fertilisation stage, whereas others have taken permissive approaches, permitting experimentation till 14 days after fertilisation. Science, nevertheless, has proven that the 14-day restrict may be moved. The creator finds it mandatory to realize broad worldwide consensus and shared laws. Lawmakers, nevertheless, must stability respect for the precept of life, represented by the embryo, towards scientific wants, in an effort to devise sound laws safeguarding each apparently conflicting basic values.

The Analysis Challenge Grant (R01) is the oldest grant mechanism utilized by the Nationwide Institutes of Well being (NIH). Receiving an R01 award is usually taken as an indication of scientific success. We introduced normative information on a number of productiveness and impression metrics for a extra goal evaluation of funded grants’ scientific success.  All preliminary R01 grants awarded by NIH within the 12 months 2000 had been prospectively adopted and evaluated utilizing the numbers of publications and citations, in addition to the h-indices on the grant degree. We examined the variability, time traits, and relations amongst these metrics to raised perceive the funded tasks’ cumulative output and impression.

Introducing Key Components Relating to Entry to Private Information for Scientific Analysis within the Perspective of Growing Revolutionary Medicines

This text goals at opening discussions and selling future analysis about key components that must be taken under consideration when contemplating new methods to organise entry to non-public information for scientific analysis within the perspective of creating revolutionary medicines. It supplies an summary of those key components: the alternative ways of accessing information, the speculation of the important services, the Regulation on the Free Move of Non-personal Information, the Directive on Open Information and the re-use of public sector data, and the Basic Information Safety Regulation (GDPR) guidelines on accessing private information for scientific analysis.

Within the perspective of fostering analysis, selling revolutionary medicines, and having all of the uncooked information centralised in huge databases localised in Europe, we advise to additional examine the likelihood to search out acceptable and balanced options with full respect of basic rights, in addition to for personal life and information safety. These embrace utilizing open science platforms, pre-registering research, making certain reproducible analyses, utilizing high-powered research, making certain open entry to analysis supplies and merchandise, and conducting replication research.

Suicide analysis is vitally vital, yet-like psychology analysis extra broadly-faces methodological challenges. In recent times, researchers have raised considerations about customary practices in psychological analysis, considerations that apply to suicide analysis and lift questions on its robustness and validity. Within the current paper, we evaluate these considerations and the corresponding options put forth by the “open science” neighborhood.

We construct upon current guides, deal with particular obstacles confronted by suicide researchers, and supply a transparent set of beneficial practices for suicide researchers. Specifically, we contemplate challenges that suicide researchers could face in searching for to undertake “open science” practices (e.g., prioritizing massive samples) and recommend attainable methods that the sector could use in an effort to guarantee strong and clear analysis, regardless of these challenges.

NIH Funding, Research Productivity, and Scientific Impact: a 20-Year Study

Enhancing open and rigorous science: ten key future analysis alternatives associated to rigor, reproducibility, and transparency in scientific analysis

As a part of a coordinated effort to broaden analysis exercise round rigor, reproducibility, and transparency (RRT) throughout scientific disciplines, a crew of investigators on the Indiana College Faculty of Public Well being-Bloomington hosted a workshop in October 2019 with worldwide leaders to debate key alternatives for RRT analysis.

The workshop aimed to establish analysis priorities and alternatives associated to RRT.  Over two-days, workshop attendees gave displays and took part in three working teams: (1) Enhancing Training & Coaching in RRT, (2) Lowering Statistical Errors and Rising Analytic Transparency, and (3) Wanting Outward: Rising Truthfulness and Accuracy of Analysis Communications. Following small-group discussions, the working teams introduced their findings, and contributors mentioned the analysis alternatives recognized. The investigators compiled an inventory of analysis priorities, which had been circulated to all contributors for suggestions.

1Kb DNA Marker

D1101-050 50㎍
EUR 131

1Kb DNA Marker

D1101-250 5X50㎍
EUR 300

2K DNA Marker

20-abx098045
  • EUR 258.00
  • EUR 189.00
  • 2.5 ml
  • 500 ul

5K DNA Marker

20-abx098048
  • EUR 258.00
  • EUR 189.00
  • 2.5 ml
  • 500 ul

15K DNA Marker

20-abx098049
  • EUR 272.00
  • EUR 189.00
  • 2.5 ml
  • 500 ul

1Kb DNA Marker

20-abx098050
  • EUR 258.00
  • EUR 189.00
  • 2.5 ml
  • 500 ul

100bp DNA Marker

20-abx098052
  • EUR 272.00
  • EUR 189.00
  • 2.5 ml
  • 500 ul

Molecular Weight Marker

abx098957-15ul 15 ul
EUR 105

KP Marker Plus

KPM-1 12 Pen(s)
EUR 117

DL5000 DNA Marker

MD102-01 250 μl
EUR 107

DL5000 DNA Marker

MD102-02 500 μl
EUR 113

DL15000 DNA Marker

MD103-01 250 μl
EUR 109

DL15000 DNA Marker

MD103-02 500 μl
EUR 115

Myeloid Cell Marker (Macrophage / Granulocyte Marker); Clone BM-1 (Concentrate)

RA0400-C.1 0.1 ml
EUR 125

Myeloid Cell Marker (Macrophage / Granulocyte Marker); Clone BM-1 (Concentrate)

RA0400-C.5 0.5 ml
EUR 300

CMV-Luciferase (No marker)

LVP911a 1x107 IFU/ml x 200ul
EUR 349
Description: Pre-made lentivirus express firefly luciferase under CMV promoter (do not containing any antibiotic selection marker), provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EF1a-Luciferase (No marker)

LVP911b 1x107 IFU/ml x 200ul
EUR 349
Description: Pre-made lentivirus express firefly luciferase under EF1a promoter (do not containing any antibiotic selection marker), provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Anti-Melanoma Marker antibody

STJ16100745 1 mL
EUR 352

Anti-Macrophage Marker antibody

STJ16100749 1 mL
EUR 478

Anti-Macrophage Marker antibody

STJ16101000 100 µg
EUR 354

Anti-Lymphocytic Marker antibody

STJ16101001 100 µg
EUR 354

Anti-Proliferation Marker antibody

STJ16101069 100 µg
EUR 354

Anti-Myeloid Marker Antibody

STJ501825 100 µg
EUR 476

Fibrillarin/Nop1p- Nucleolar Marker

MO22108 500 ul
EUR 344

HyperPAGE Prestained Protein Marker

BIO-33066 500µl Ask for price

Peacock Prestained Protein Marker

9-21530
  • EUR 189.00
  • EUR 111.00
  • 500UL
  • 50UL
Description: Minimum order quantity: 1 unit of 50UL

Histiocytoma Marker(D11) Antibody

BNC040348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF405S conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC040348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF405S conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC040719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF405S conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC040719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF405S conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC040740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF405S conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC040740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF405S conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC040754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF405S conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC040754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF405S conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC040894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF405S conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC040894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF405S conjugate, Concentration: 0.1mg/mL

1Kb Plus DNA Marker

20-abx098051
  • EUR 300.00
  • EUR 203.00
  • 2.5 ml
  • 500 ul

Histiocytoma Marker(D11) Antibody

BNC470348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF647 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC470348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC470719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC470719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC470740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC470740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC470754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC470754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF647 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC470894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF647 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC470894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF647 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC550348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF555 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC550348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF555 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNCAP0348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNCAP0348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNCAP0719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNCAP0719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNCAP0740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNCAP0740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNCAP0754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNCAP0754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCAP0894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCAP0894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNCB0348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), Biotin conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNCB0348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNCB0719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNCB0719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNCB0740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNCB0740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNCB0754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNCB0754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), Biotin conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCB0894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), Biotin conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCB0894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), Biotin conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC810348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF680R conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC810348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC810719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC810719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC810740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC810740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC810754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC810754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF680R conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC810894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF680R conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC810894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF680R conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC700348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF770 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC700348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF770 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC700719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF770 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC700719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF770 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC700740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF770 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC700740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF770 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC700754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF770 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC700754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF770 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC700894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF770 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC700894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF770 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC880348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF488A conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC880348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF488A conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC880719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF488A conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC880719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF488A conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC880740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF488A conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC880740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF488A conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC880754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF488A conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC880754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF488A conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC880894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF488A conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC880894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF488A conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC940348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF594 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC940348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF594 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC610719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF660R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC610719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF660R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC610740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF660R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC610740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF660R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC610754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF660R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC610754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF660R conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC610894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF660R conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC610894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF660R conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC680348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF568 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC680348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF568 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC680719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF568 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC680719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF568 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC680740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF568 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC680740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF568 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC680754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF568 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC680754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF568 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC680894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF568 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC680894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF568 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNCA0348-250 250uL
EUR 383
Description: Primary antibody against Histiocytoma Marker(D11), APC conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNCA0719-250 250uL
EUR 383
Description: Primary antibody against Mitochondrial Marker(MTC719), APC conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNCA0740-250 250uL
EUR 383
Description: Primary antibody against Mitochondrial Marker(MTC02), APC conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNCA0754-250 250uL
EUR 383
Description: Primary antibody against Mitochondrial Marker(MTC754), APC conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCA0894-250 250uL
EUR 383
Description: Primary antibody against Melanoma Marker(PNL2), APC conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNUM0348-50 50uL
EUR 395
Description: Primary antibody against Histiocytoma Marker(D11), 1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNUM0719-50 50uL
EUR 395
Description: Primary antibody against Mitochondrial Marker(MTC719), 1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNUM0740-50 50uL
EUR 395
Description: Primary antibody against Mitochondrial Marker(MTC02), 1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNUM0754-50 50uL
EUR 395
Description: Primary antibody against Mitochondrial Marker(MTC754), 1mg/mL

Melanoma Marker(PNL2) Antibody

BNUM0894-50 50uL
EUR 395
Description: Primary antibody against Melanoma Marker(PNL2), 1mg/mL

Histiocytoma Marker(D11) Antibody

BNCP0348-250 250uL
EUR 383
Description: Primary antibody against Histiocytoma Marker(D11), PerCP conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNCP0719-250 250uL
EUR 383
Description: Primary antibody against Mitochondrial Marker(MTC719), PerCP conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNCP0740-250 250uL
EUR 383
Description: Primary antibody against Mitochondrial Marker(MTC02), PerCP conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNCP0754-250 250uL
EUR 383
Description: Primary antibody against Mitochondrial Marker(MTC754), PerCP conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC050348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF405M conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC050348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF405M conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC050719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF405M conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC050719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF405M conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC050740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF405M conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody

BNC050740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF405M conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC050754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF405M conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody

BNC050754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF405M conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC050894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF405M conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC050894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF405M conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC400348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF640R conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody

BNC400348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF640R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody

BNC400719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF640R conjugate, Concentration: 0.1mg/mL

Members recognized the next precedence analysis questions: (1) Can RRT-focused statistics and mathematical modeling programs enhance statistics apply?; (2) Can specialised coaching in scientific writing enhance transparency?; (3) Does modality (e.g. nose to nose, on-line) have an effect on the efficacy RRT-related schooling?; (4) How can automated packages assist establish errors extra effectively?; 

What’s the prevalence and impression of errors in scientific publications (e.g., analytic inconsistencies, statistical errors, and different goal errors)?; (6) Do error prevention workflows cut back errors?; (7) How can we encourage post-publication error correction?; (8) How does ‘spin’ in analysis communication have an effect on stakeholder understanding and use of analysis proof?; (9) Do instruments to assist writing analysis studies enhance comprehensiveness and readability of analysis studies?; and (10) Is it attainable to inculcate scientific values and norms associated to truthful, rigorous, correct, and complete scientific reporting? Members recognized vital and comparatively unexplored questions associated to bettering RRT. This record could also be helpful to the scientific neighborhood and investigators searching for to advance meta-science (i.e. analysis on analysis).

Reporting consciousness in coma: media framing of neuro-scientific research, hope, and the response of families with relatives in vegetative and minimally conscious states

Reporting consciousness in coma: media framing of neuro-scientific research, hope, and the response of families with relatives in vegetative and minimally conscious states

This paper examines the general public illustration of, and household responses to, scientific research into consciousness in coma-like states. We look at the publicity surrounding high-profile research utilizing purposeful Magnetic Resonance Imaging (fMRI) on ‘vegetative’ or ‘minimally aware’ sufferers and evaluate this with household views. Our findings present how, with a couple of notable exceptions, the analysis was offered as a tremendous breakthrough providing a possible ‘voice’ and selection for sufferers and hope and luxury for his or her households. We argue that such representations ignored key limitations, evoked unrealistic visions of restoration, and promoted very slim representations of household reactions.

The comparability between public representations of the science and responses from households with expertise of this situation highlights the complicated social/medical world into which neurotechnologies intervene, and factors to the absence of a variety of affected person/household views in public discourse. We conclude with recommendations for the way these selling the analysis, and the journalists reporting its implications, may act to make sure extra accountable protection and improve public debate.

First, we affirm earlier analysis in suggesting that e-cigarettes appeared to have triggered a breakdown of outdated public well being alliances. Second, we display that, amid issues about analysis high quality and amount, actors are guided by normative outlooks (and/or financial pursuits) of their assessments of proof. Third, we present that, regardless of describing e-cigarette debates as contentious and polarised, actors partaking in Scottish coverage debates exhibit a spectrum of views, with most interviewees occupying an unsure ‘center floor’ that’s attentive to new proof.

Fourth, we propose that the perceived divisiveness of e-cigarette debates is attributed to recurrent media simplifications and tensions arising from the behaviours of some actors with settled positions working to advertise explicit coverage responses (together with by strategically enrolling supportive proof). Fifth, we argue that the actions of those actors are doubtlessly defined by the prospect that e-cigarettes may usher in a brand new tobacco ‘coverage paradigm’. Lastly, we present how scientific authority is employed as a device inside these debates.

Chemosensory Programs in COVID-19: Evolution of Scientific Analysis

COVID-19 illness induced by coronavirus SARS-CoV-2 presents amongst its signs alterations of the chemosensory capabilities. Within the first research on the Chinese language inhabitants, this symptomatology was not notably related, and hyposmia and hypogeusia have been excluded from the signs to be evaluated to diagnose the illness. With the pandemic unfold of the sickness, there was an increase in reviews on chemosensory dysfunctions amongst sufferers. The primary information evaluation confirmed the presence of those problems primarily in paucisymptomatic and asymptomatic sufferers. The curiosity in chemosensory techniques due to this fact elevated significantly, as a result of the olfactory and gustatory signs could possibly be the important thing to cease the an infection unfold.
Moreover, the diploma of alert and a focus grew, contemplating that these kind of dysfunctions are prognostic signs of significant neurodegenerative illnesses. About 9 months have handed because the first anecdotal reviews on the involvement of the olfactory and gustatory techniques within the COVID-19 pathology. Because of this, a cautious evaluation of the literature was performed to grasp whether it is clearer which individuals current chemosensory signs and if these are associated to the severity of the illness. Moreover, we have now recognized which facets nonetheless stay to be clarified. This novel consequence may be defined with self-determination of students as an important determinant supporting scientific manufacturing that outclasses shrinking public analysis lab budgets and organizational deficiencies.
Throughout the early levels of the pandemic, analysis performed on hydroxychloroquine (HCQ) was chaotic and sparked a number of heated debates with respect to the scientific strategies used and the standard of data generated. Analysis on HCQ is used as a case research in each papers. The authors explored biomedical databases, peer-reviewed journals, pre-print servers, and media articles to establish related literature on HCQ and COVID-19, and examined philosophical views on medical analysis within the context of this pandemic and former world well being challenges.
Reporting consciousness in coma: media framing of neuro-scientific research, hope, and the response of families with relatives in vegetative and minimally conscious states

How self-determination of students outclasses shrinking public analysis lab budgets, supporting scientific manufacturing: a case research and R&D administration implications

The principle objective of this research is to research how reorganization of public analysis organizations and shrinking public analysis lab budgets have an effect on the evolution of analysis exercise and scientific productiveness. This research focuses on a case research of Nationwide Analysis Council of Italy (CNR), one among largest European public analysis organizations, to establish evolution of analysis actions and dynamics of scientific manufacturing from 2000 to 2019. The statistical evaluation means that, consistent with the origin of the CNR, scientific analysis focuses primarily on analysis fields of pure sciences, comparable to chemical, life and bodily sciences, with an growing position of scientific analysis in power, engineering and arithmetic.

Dog DNA (Double Stranded) ELISA kit

E08A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Canine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog DNA (Double Stranded) ELISA kit

E08A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Canine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog DNA (Double Stranded) ELISA kit

E08A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Canine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human DNA (Double Stranded) ELISA kit

E01A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Human DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human DNA (Double Stranded) ELISA kit

E01A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Human DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human DNA (Double Stranded) ELISA kit

E01A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Human DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit DNA (Double Stranded) ELISA kit

E04A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Rabbit DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit DNA (Double Stranded) ELISA kit

E04A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Rabbit DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit DNA (Double Stranded) ELISA kit

E04A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Rabbit DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse DNA (Double Stranded) ELISA kit

E03A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Mouse DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse DNA (Double Stranded) ELISA kit

E03A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Mouse DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse DNA (Double Stranded) ELISA kit

E03A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Mouse DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat DNA (Double Stranded) ELISA kit

E02A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Rat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat DNA (Double Stranded) ELISA kit

E02A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Rat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat DNA (Double Stranded) ELISA kit

E02A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Rat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat DNA (Double Stranded) ELISA kit

E06A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Goat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat DNA (Double Stranded) ELISA kit

E06A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Goat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat DNA (Double Stranded) ELISA kit

E06A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Goat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig DNA (Double Stranded) ELISA kit

E07A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Porcine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig DNA (Double Stranded) ELISA kit

E07A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Porcine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig DNA (Double Stranded) ELISA kit

E07A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Porcine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC040945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC040945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC040946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC040946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC040958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC040958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC470945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC470945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC470946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC470946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC470958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC470958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNCAP0945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNCAP0945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNCAP0946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNCAP0946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNCAP0958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNCAP0958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNCB0945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNCB0945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNCB0946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNCB0946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNCB0958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNCB0958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC810945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC810945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC810946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC810946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC810958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC810958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC700945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC700945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC700946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC700946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC700958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC700958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC880945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC880945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC880946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC880946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC880958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC880958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC610945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC610945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC610946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC610946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC610958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC610958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC680945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC680945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC680946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC680946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC680958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC680958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNCA0945-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), APC conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNCA0946-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), APC conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNCA0958-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), APC conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNUM0945-50 50uL
EUR 395
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), 1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNUM0946-50 50uL
EUR 395
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), 1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNUM0958-50 50uL
EUR 395
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), 1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC050945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC050945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC050946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC050946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC050958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC050958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNCP0945-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), PerCP conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNCP0946-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), PerCP conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNCP0958-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), PerCP conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNCR0945-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), RPE conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNCR0946-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), RPE conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNCR0958-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), RPE conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNUB0945-100 100uL
EUR 209
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Concentration: 0.2mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNUB0945-500 500uL
EUR 458
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Concentration: 0.2mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNUB0946-100 100uL
EUR 209
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Concentration: 0.2mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNUB0946-500 500uL
EUR 458
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Concentration: 0.2mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNUB0958-100 100uL
EUR 209
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Concentration: 0.2mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNUB0958-500 500uL
EUR 458
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Concentration: 0.2mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC430945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF543 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC430945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF543 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC430946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF543 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC430946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF543 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC430958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF543 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC430958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF543 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNCH0945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNCH0945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNCH0946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNCH0946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNCH0958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNCH0958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC550945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF555 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC550945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF555 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC550946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF555 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC550946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF555 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC550958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF555 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody

BNC550958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF555 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC940945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF594 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody

BNC940945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF594 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC940946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF594 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody

BNC940946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF594 conjugate, Concentration: 0.1mg/mL

The research additionally exhibits a excessive depth of collaboration of the CNR inside worldwide analysis networks. A key discovering of this research is to indicate, for the primary time, that though unsure reforms and reductions of public funds, scientific productiveness is rising. The administration and analysis coverage implications of this research may be generalized to help an environment friendly organizational and managerial conduct, and better scientific productiveness of public analysis institutes in contexts of lowered public funding and market turbulence.

fiddle: a tool to combat publication bias by getting research out of the file drawer and into the scientific community

fiddle: a tool to combat publication bias by getting research out of the file drawer and into the scientific community

Statistically important findings usually tend to be revealed than non-significant or null findings, leaving scientists and healthcare personnel to make choices based mostly on distorted scientific proof. Repeatedly increasing ´file drawers’ of unpublished information from well-designed experiments waste assets creates issues for researchers, the scientific group and the general public. There may be restricted consciousness of the unfavourable impression that publication bias and selective reporting have on the scientific literature.

Various publication codecs have lately been launched that make it simpler to publish analysis that’s tough to publish in conventional peer reviewed journals. These embody micropublications, information repositories, information journals, preprints, publishing platforms, and journals specializing in null or impartial outcomes. Whereas these different codecs have the potential to scale back publication bias, many scientists are unaware that these codecs exist and do not know how one can use them.

Our open supply file drawer information liberation effort (fiddle) software is a match-making Shiny app designed to assist biomedical researchers to establish essentially the most applicable publication format for his or her information. Customers can seek for a publication format that meets their wants, evaluate and distinction totally different publication codecs, and discover hyperlinks to publishing platforms. This software will help scientists in getting in any other case inaccessible, hidden information out of the file drawer into the scientific group and literature.

Pitfalls in scientific analysis: vital appraisal of articles revealed in one of many worldwide journals in Egypt

To establish and report flaws of Web-published articles within the Journal of the Egyptian Nationwide Most cancers Institute (JENCI), Cairo College, by means of a retrospective documentary research on articles revealed through the interval from 2011 to 2016. All sections have been reviewed in opposition to a collective guidelines. Articles have been grouped by publication yr into 2 intervals: early (from 2011 to 2013) and up to date (from 2014 to 2016) to establish adjustments in research traits over time. The research included 139 unique articles. Half of the titles represented purpose and 9.4% represented research design.
Abstracts have been concise, clear, with structured writing format in 98.6%, 93.5%, and 35.3%, respectively. Most introductions included the research purpose, whereas 41% had a rationale. Examine timing was reported in 59.0%, whereas the research design was reported in 25.9%. Inclusion and exclusion standards have been clearly reported in 43.1% and 40.1%, respectively. Statistical strategies have been talked about in 80.6%, full in 30.4%, and applicable in 85.7%. We briefly spotlight important particulars that ought to be included to make sure reporting high quality, which is able to enable others to make use of and profit from analysis revealed in these new codecs.
4 research reported pattern measurement estimation. Solely 52.5% and 58.3% of outcomes have been exhaustive and reply the analysis query, respectively. Incorrect statistical calculations occurred in 41.0%, inappropriate statistical checks or descriptive parameter choice in 26.6%, whereas inappropriate take a look at software occurred in 49.1%. About 60% of discussions didn’t fully cowl outcomes, 31.7% totally justified the findings, 56.1% adopted a logical circulate, and 36.7% had contradiction inside the textual content. Conclusions have been principally linked to purpose, imprecise, and extrapolating past outcomes.
On evaluating each intervals, solely a major much less misuse of statistical phrases, extra reporting battle of curiosity, extra lacking references for cited texts within the current interval, and extra participation of NCI over different institutes within the early interval have been discovered. Articles revealed in JENCI (from 2011 to 2016) had many methodological and reporting defects and a few factors of energy. Utilizing the collective guidelines developed by this research, steady coaching of researchers, involving epidemiologists all through the entire analysis course of, and making use of strict journal reporting and publication guidelines ought to be inspired.
fiddle: a tool to combat publication bias by getting research out of the file drawer and into the scientific community

A complete bibliometrics of ‘walkability’ analysis panorama: visualization of the scientific progress and future prospects

This research quantitatively investigated the scientific progress of walkability analysis panorama and its future prospects utilizing bibliometric indicators to spotlight the analysis hotspots. The outcomes accentuated multifaceted nature of walkability analysis panorama with a robust affiliation in direction of public well being disciplines. Key phrase co-occurrence evaluation emphasised that majority of the walkability research centred on the interactions between strolling and different three predominant elements resembling constructed atmosphere attributes, transportation and weight problems.

Plasmid ezFilter Midi Kit I, Centrifuge

K1316-2
EUR 262

Plasmid ezFilter Midi Kit I, Centrifuge

K1316-25
EUR 425

ToxOut? Endofree ezFilter Plasmid Midi Kit

K1329-10
EUR 316

ToxOut? Endofree ezFilter Plasmid Midi Kit

K1329-2
EUR 207

ToxOut? Endofree ezFilter Plasmid Midi Kit

K1329-25
EUR 533

Plasmid Midi Kit II

K1315-10
EUR 370

Plasmid Midi Kit II

K1315-2
EUR 262

Plasmid Midi Kit II

K1315-25
EUR 425

BlotBot Midi Blot Tray

TRAY-MIDI-2 2pack
EUR 202
Description: Replacement tray for the BlotBot allows you to run 1 Midi sized blot. Pack of 2 trays.

Plasmid ezFilter Maxi Kit

K1319-10
EUR 392

Plasmid ezFilter Maxi Kit

K1319-25
EUR 610

Plasmid ezFilter Mega3 Kit

K1320-1
EUR 262

Plasmid ezFilter Mega3 Kit

K1320-10
EUR 887

Plasmid ezFilter Mega3 Kit

K1320-2
EUR 343

Plasmid ezFilter Mega6 Kit

K1321-1
EUR 283

Plasmid ezFilter Mega6 Kit

K1321-10
EUR 968

Plasmid ezFilter Mega6 Kit

K1321-2
EUR 370

Plasmid ezFilter Mega10 Kit

K1322-1
EUR 343

Plasmid ezFilter Mega10 Kit

K1322-10
EUR 1104

Plasmid ezFilter Mega10 Kit

K1322-2
EUR 452

Plasmid Midi Kit I

K1314-10
EUR 332

Plasmid Midi Kit I

K1314-2
EUR 262

Plasmid Midi Kit I

K1314-25
EUR 392

Fast Ion Plasmid Midi Kit

FYG002-25P 25 Preps Ask for price

ToxOut? Endofree Plasmid Midi Kit

K1328-10
EUR 316

ToxOut? Endofree Plasmid Midi Kit

K1328-2
EUR 207

ToxOut? Endofree Plasmid Midi Kit

K1328-25
EUR 479

96-well Plasmid ezFilter Mini Kit

K1325-96-1
EUR 370

96-well Plasmid ezFilter Mini Kit

K1325-96-4
EUR 968

ToxOut? Endofree ezfilter Plasmid Maxi Kit

K1331-10
EUR 425

ToxOut? Endofree ezfilter Plasmid Maxi Kit

K1331-2
EUR 234

ToxOut? Endofree ezfilter Plasmid Maxi Kit

K1331-25
EUR 642

Human Drug Detoxication II

HDTX-II 1 set
EUR 645

Human Kinase Library II

HKIN-II 1 set
EUR 450

T-Pro Plasmid Midi Kit (20)

RB94-YPI020 20preps/Kit
EUR 213

ToxOut? Express Endofree Plasmid Midi Kit

K1335-10
EUR 370

ToxOut? Express Endofree Plasmid Midi Kit

K1335-2
EUR 234

ToxOut? Express Endofree Plasmid Midi Kit

K1335-25
EUR 697

Human Cytokine Primer Library II

HCA-II 1 set
EUR 450

Mouse Cytokine Primer Library II

MCA-II 1 set
EUR 450

Rat Cytokine Primer Library II

RCA-II 1 set
EUR 548

Human Colon Cancer Primer Library II

HCCP-II 1 set
EUR 548

Human DNA Repair Primer Library II

HDRL-II 1 set
EUR 548

Mouse DNA Repair Primer Library II

MDRL-II 1 set
EUR 645

Human Cancer Driver Gene II Primer Library

HCDG-II 1 set
EUR 645

Human Interferon Type II Signaling Primer Library

HIFN-II 1 set
EUR 548

Fast Ion Plasmid Midi KitEndotoxin Free

FYG003-25P 25 Preps Ask for price

Plasmid DNA Extraction Midi Kit (25prep), Ion Exchange

FAPDE-002 25 preps
EUR 216

Plasmid DNA Extraction Midi Kit (50prep), Ion Exchange

FAPDE-002-1 50 preps
EUR 317

High Speed Plasmid Midi Kit (25prep), Ion Exchange

FAPDE-002-SP2 25 preps
EUR 361

FavorFilter Plasmid Midi SP Kit (25prep)-spin column

FAPDE-005-M-025 25 preps
EUR 150

FavorFilter Plasmid Midi SP Kit (50prep)-spin column

FAPDE-005-M-050 50 preps
EUR 187

T-Pro Endotoxin Removal Plasmid Midi kit (25)

RB94-EPI020 20preps/Kit
EUR 248

Plasmid DNA Extraction Midi Kit (25prep), FavorFilter, Ion Exchange

FAFTE-002 25 preps
EUR 245

Plasmid DNA Extraction Midi Kit (50prep), FavorFilter, Ion Exchange

FAFTE-002-1 50 preps
EUR 368

Plasmid DNA Extraction Midi Kit (25prep), EndoToxinFree, Ion Exchange

FAPDE-002-EF 25 preps
EUR 230

Plasmid DNA Midi Endotoxin Removal kit(25prep)-spin column

FAPDE-005B-025 25 preps
EUR 165

Plasmid DNA Midi Endotoxin Removal kit(50prep)-spin column

FAPDE-005B-050 50 preps
EUR 227

CMV-hspCas9-T2A-Puro SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit

CASLV100PA-KIT 1 Kit
EUR 1132

CMV-hspCas9-EF1-GFP SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit

CASLV105PA-KIT 1 Kit
EUR 1132

MSCV-hspCas9-T2A-Puro SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit

CASLV120PA-KIT 1 Kit
EUR 1132

MSCV-hspCas9-EF1-GFP SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit

CASLV125PA-KIT 1 Kit
EUR 1132

Cas9 Nickase: CMV-hspCas9(D10A)-T2A-Puro SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit

CASLV200PA-KIT 1 Kit
EUR 1132

Cas9 Nickase: CMV-hspCas9(D10A)-EF1-GFP SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit

CASLV205PA-KIT 1 Kit
EUR 1132

Cas9 Nickase: MSCV-hspCas9(D10A)-T2A-Puro SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit

CASLV220PA-KIT 1 Kit
EUR 1132

Cas9 Nickase: MSCV-hspCas9(D10A)-EF1-GFP SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit

CASLV225PA-KIT 1 Kit
EUR 1132

Plasmid Miniprep Kit II

K1313-250
EUR 370

Plasmid Miniprep Kit II

K1313-50
EUR 283

Soil DNA Isolation Midi Kit (24prep)

FASOI-002 24 preps
EUR 216

ISOLATE II Plasmid Mini Kit

BIO-52055 10 preps Ask for price

ISOLATE II Plasmid Mini Kit

BIO-52056 50 preps Ask for price

ISOLATE II Plasmid Mini Kit

BIO-52057 250 preps Ask for price

pCold II Plasmid

PVT0602 2 ug
EUR 301

T-Pro Genomic DNA Midi Kit (20)

RB94-NGM020 20preps/kit
EUR 222

midi horizontal unit 10x7 cm

EHS1201-SYS ea
EUR 352

midi horizontal unit 10x10 cm

EHS1202-SYS ea
EUR 352

midi horizontal unit 15x15 cm

EHS3400-SYS ea
EUR 631

midi horizontal unit 15x25 cm

EHS3410-SYS ea
EUR 775

midi horizontal unit 20x25 cm

EHS3500-SYS ea
EUR 817

midi gel dryer 21x31 cm

EDRY1100 ea
EUR 1873

Frit Kit

FRIT-KIT 1each
EUR 124
Description: Kit to create frits in capillaries. Includes formamide, Kasil-1, Kasil-1624 and a cleaving tool.

ToxOut? Endofree Plasmid Mini Kit II

K1327-250
EUR 697

ToxOut? Endofree Plasmid Mini Kit II

K1327-50
EUR 272

Holder for Plasmid Midi, Maxi and Maxi plus, Ion Exchange column

FAPDE-holder-for-ion-exchange 1 prep
EUR 158

Column Packing Kit

PACK-KIT 1pack
EUR 1035
Description: Column packing kit for pressure cells. Includes: HPREG regulator, TBNG10 tubing, CAP-75 capillary, and STRB5X2 stir bar.

pBluescript II SK+ Plasmid

PVT0011 2 ug
EUR 301

pBluescript II KS+ Plasmid

PVT0012 2 ug
EUR 301

Attoglow Western Blot Analysis Kit- with Millennium Enhancer, Anti rabbit secondary antibody

K3171120-II 1200 cm2
EUR 246
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Attoglow Western Blot Analysis Kit- with Millennium Enhancer, Anti rabbit secondary antibody

K3171250-II 2500 cm2
EUR 310
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

RapidSeq High Yield Directional mRNA Sample Prep Kit - With Aligner 13-24

KS073012-II 1 Kit
EUR 1142
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol.

RapidSeq High Yield Small RNA Sample Prep Kit - With Aligner 13-24

KS074012-II 1 Kit
EUR 1021
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol.

PCR Mycoplasma Detection Kit

M034-Kit Kit
EUR 266

T-Pro Plant Genomic DNA Midi Kit (20)

RB94-PGM020 20preps/kit
EUR 222

semi dry blotter midi 20x20 cm

ESDB1200 ea
EUR 1113

semi dry blotter midi 20x20 cm

ESDB3200 ea
EUR 1239

midi horizontal unit 10x7 & 10x10 cm

EHS1200-SYS ea
EUR 378

supporting mask for midi gel dryer

EDRY1100-MASK ea
EUR 301

ssilicone rubber for midi gel dryer

EDRY1100-SILRUB ea
EUR 90

ICE PAN, RECTANGULAR, MIDI, 4L, GREEN

432103 1/pk
EUR 131
Description: BioCision; BioCision TruCool

ICE PAN, RECTANGULAR, MIDI, 4L, BLUE

432104 1/pk
EUR 131
Description: BioCision; BioCision TruCool

ICE PAN, RECTANGULAR, MIDI, 4L, RED

432105 1/pk
EUR 131
Description: BioCision; BioCision TruCool

ICE PAN, RECTANGULAR, MIDI, 4L, ORANGE

432106 1/pk
EUR 131
Description: BioCision; BioCision TruCool

ICE PAN, RECTANGULAR, MIDI, 4L, PINK

432108 1/pk
EUR 131
Description: BioCision; BioCision TruCool

ICE PAN, RECTANGULAR, MIDI, 4L, PURPLE

432109 1/pk
EUR 131
Description: BioCision; BioCision TruCool

Cas9 Protein and T7 gRNA SmartNuclease Synthesis Kit

CAS400A-KIT 1 kit (10 rxn)
EUR 1110

Multiplex gRNA Kit + EF1-T7-hspCas9-H1-gRNA linearized SmartNuclease vector

CAS700A-KIT 10 rxn
EUR 1132

Multiplex gRNA Kit + CAG-T7-hspCas9-H1-gRNA linearized SmartNuclease vector

CAS720A-KIT 10 rxn
EUR 1132

Multiplex gRNA Kit + CMV-T7-hspCas9-H1-gRNA linearized SmartNuclease vector

CAS740A-KIT 10 rxn
EUR 1132

T7 gRNA SmartNuclease Synthesis Kit (includes CAS510A-1 & T7 IVT synthesis reagents)

CAS510A-KIT 1 Kit
EUR 805

pBluescript II SK-DCLK1 Plasmid

PVTB00129S 2 ug
EUR 356

pGreen II 62-SK Plasmid

PVT3026 2 ug
EUR 356

Multiplex gRNA Kit + Cas9 Nickase: EF1-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector

CAS750A-KIT 10 rxn
EUR 1132

Multiplex gRNA Kit + Cas9 Nickase: CAG-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector

CAS770A-KIT 10 rxn
EUR 1132

Multiplex gRNA Kit + Cas9 Nickase: CMV-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector

CAS790A-KIT 10 rxn
EUR 1132

Cas9 SmartNuclease Extra Ligation Kit [includes 5x ligation buffer (10 ul) and Fast ligase (2.5ul)]

CAS9LIG-KIT 1 Kit
EUR 153

ICE PAN, RECTANGULAR, MIDI, 4L, LIME GREEN

432107 1/pk
EUR 131
Description: BioCision; BioCision TruCool

PinPoint-FC 293T Platform Kit for Targeted Gene Insertion (includes PIN320A-1, PIN200A-1, PIN510A-1 & PIN600A-1)

PIN320A-KIT 1 Kit
EUR 4941

PinPoint-FC Murine iPSC Platform Kit for Targeted Gene Insertion (includes PIN340iPS-1, PIN200A-1, PIN510A-1 & PIN600A-1)

PIN340iPS-KIT 1 Kit
EUR 4941

Aligner 13-24

KS072012-II 1 Kit
EUR 412
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol.

AAVS1 Safe Harbor Targeting Vector 2.0 - All-Purpose Donor (AAVS1-SA-puro-MCS), Complete Kit with CAS601A-1 (Cas9 SmartNuclease AAVS1-gRNA Targeting Vector) and GE640PR-1 (Junction PCR Primer Mix to confirm AAVS1 integration site)

GE620A-KIT 1 kit
EUR 2132

AAVS1 Safe Harbor Targeting Vector 2.0 - GOI Knock-in Donor (AAVS1-SA-puro-EF1-MCS), Complete Kit with CAS601A-1 (Cas9 SmartNuclease AAVS1-gRNA Targeting Vector) and GE640PR-1 (Junction PCR Primer Mix to confirm AAVS1 integration site)

GE622A-KIT 1 kit
EUR 2132

AAVS1 Safe Harbor Targeting Vector 2.0 - Reporter Knock-in Donor (AAVS1-SA-puro-MCS-GFP), Complete Kit with CAS601A-1 (Cas9 SmartNuclease AAVS1-gRNA Targeting Vector) and GE640PR-1 (Junction PCR Primer Mix to confirm AAVS1 integration site)

GE624A-KIT 1 kit
EUR 2132

pCR-Blunt II-TOPO-MYRIP Plasmid

PVT15980 2 ug
EUR 325

Primarily based on the recognized analysis hotspots, a quick state-of-the-art overview of walkability research was offered. Future prospects based mostly on the unexplored analysis gaps inside the hotspots have been additionally mentioned. Excessive correlation (r = 0.99, p < 0.05) between annual publications and quotation counts demonstrated the importance of walkability research to the modern scientific group. Being one of many complete research to guage the historic trajectory of walkability analysis panorama, the findings have been anticipated to speed up a complete understanding of the walkability analysis area that can help future analysis route.